Armistice Capital, LLC

Armistice Capital, LLC is a declared insider at 19 companies; the most frequent names are Avalo Therapeutics, Inc., Del Frisco's Restaurant Group, Inc. and Kiora Pharmaceuticals Inc. Between 6 July 2017 and 26 June 2023, the trades on record add up to 1,268 filings.

Market trades split into 1,065 purchases (€74.9M) and 151 sales (€332.1M). The totals do not cover 665 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 13 share grants and 10 option exercises. So far in 2023, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €30k. Of 371 purchases, 100 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 11 purchases with a full 90-day history, the hit rate stands at 9% and the median 90-day move at -32.1%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 28 June 2023 with an open-market sale (€1.5M) in Avalo Therapeutics, Inc. The most recent open-market purchase was published on 14 March 2022, 1,685 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.